Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

December 1, 2039

Study Completion Date

December 1, 2039

Conditions
Non Hodgkin Lymphoma
Interventions
OTHER

Long-term Follow-Up

No intervention

Trial Locations (5)

21201

NOT_YET_RECRUITING

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore

53226

RECRUITING

Froedtert Hospital and the Medical College of Wisconsin, Milwaukee

94305

RECRUITING

Stanford University, Stanford

06520

RECRUITING

Yale University, New Haven

02215

RECRUITING

Dana Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
lead

Miltenyi Biomedicine GmbH

INDUSTRY